Larimar Therapeutics Inc (LRMR)

$4.38 -0.02 (-0.45%)
Market Cap 476.00M
Revenue (ttm) 0.00
Net Income (ttm) -80.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,422,800
Avg Vol 4,736,188
Day's Range N/A - N/A
Shares Out 103.59M
Stochastic %K 5%
Beta 0.91
Analysts Strong Sell
Price Target $16.60

Company Profile

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Industry: Biotechnology
Sector: Healthcare
Phone: 844 511 9056
Address:
Three Bala Plaza East, Suite 506, Bala Cynwyd, United States
DynamicResearch
DynamicResearch Mar. 18 at 6:32 AM
$LRMR appeared on scans, just noting it.
0 · Reply
nopennys
nopennys Mar. 17 at 9:49 PM
$LRMR https://seekingalpha.com/article/4860443-larimar-therapeutics-the-market-is-mispricing-a-potential-standard-of-care
0 · Reply
Nescu
Nescu Mar. 17 at 8:05 PM
$LRMR 27% decline from the previous top. Continuation or just boom and bust? Time will tell, but congrats to all shorts so far, you nailed it!
1 · Reply
Tony_37
Tony_37 Mar. 17 at 5:37 PM
$LRMR : no news yet 🤔waiting game
0 · Reply
BiotechStockFundManager
BiotechStockFundManager Mar. 17 at 3:53 PM
$LRMR Bought more shares today. This and $CRVS are my top two stocks.
0 · Reply
Nescu
Nescu Mar. 17 at 3:34 PM
$LRMR Even the most uninformed investor feels the huge potential here. Their drug is 11 months away from approval in an area where the current standard of care sold for 7.2 billion. This drug only manages the disease while nomlo could critically modify the disease. It is crazy that we not trading at 10 dollars now. It is just a matter of time.
0 · Reply
Rolex53
Rolex53 Mar. 17 at 2:55 PM
$LRMR 3.9 pls to load up.
0 · Reply
BioResearcher
BioResearcher Mar. 17 at 12:44 PM
$LRMR I added 5K shares yesterday @ 4.37 Insiders have great confidence here: Insiders just bought $25 mils stock few weeks ago, In fact, Insiders have been buying big without selling any shares for last few years:
0 · Reply
ibaian
ibaian Mar. 17 at 4:02 AM
$LRMR $ 12 in few weeks
0 · Reply
Tony_37
Tony_37 Mar. 16 at 9:20 PM
$LRMR insider bought at $5 so let’s see 💎
0 · Reply
Latest News on LRMR
No data available.
DynamicResearch
DynamicResearch Mar. 18 at 6:32 AM
$LRMR appeared on scans, just noting it.
0 · Reply
nopennys
nopennys Mar. 17 at 9:49 PM
$LRMR https://seekingalpha.com/article/4860443-larimar-therapeutics-the-market-is-mispricing-a-potential-standard-of-care
0 · Reply
Nescu
Nescu Mar. 17 at 8:05 PM
$LRMR 27% decline from the previous top. Continuation or just boom and bust? Time will tell, but congrats to all shorts so far, you nailed it!
1 · Reply
Tony_37
Tony_37 Mar. 17 at 5:37 PM
$LRMR : no news yet 🤔waiting game
0 · Reply
BiotechStockFundManager
BiotechStockFundManager Mar. 17 at 3:53 PM
$LRMR Bought more shares today. This and $CRVS are my top two stocks.
0 · Reply
Nescu
Nescu Mar. 17 at 3:34 PM
$LRMR Even the most uninformed investor feels the huge potential here. Their drug is 11 months away from approval in an area where the current standard of care sold for 7.2 billion. This drug only manages the disease while nomlo could critically modify the disease. It is crazy that we not trading at 10 dollars now. It is just a matter of time.
0 · Reply
Rolex53
Rolex53 Mar. 17 at 2:55 PM
$LRMR 3.9 pls to load up.
0 · Reply
BioResearcher
BioResearcher Mar. 17 at 12:44 PM
$LRMR I added 5K shares yesterday @ 4.37 Insiders have great confidence here: Insiders just bought $25 mils stock few weeks ago, In fact, Insiders have been buying big without selling any shares for last few years:
0 · Reply
ibaian
ibaian Mar. 17 at 4:02 AM
$LRMR $ 12 in few weeks
0 · Reply
Tony_37
Tony_37 Mar. 16 at 9:20 PM
$LRMR insider bought at $5 so let’s see 💎
0 · Reply
TKkamen
TKkamen Mar. 16 at 6:20 PM
$LRMR Thought I was getting a good deal at $5...
0 · Reply
Tony_37
Tony_37 Mar. 16 at 6:19 PM
$LRMR : back to $5 first 😅
0 · Reply
Nescu
Nescu Mar. 16 at 5:26 PM
$LRMR What a joke of a price action!
0 · Reply
Nescu
Nescu Mar. 16 at 4:33 PM
$LRMR The shorts add on winners until the trend is reversed and then the bulls are in control. The thing is that with Larimar the valuation dictates the price, which currently is undervalued based on the earnings potential of a derisked asset.
1 · Reply
Nescu
Nescu Mar. 16 at 4:31 PM
$LRMR It's oversold, it will bounce soon running with the fundamentals which are at the best of the company since IPO.
0 · Reply
kenny91655
kenny91655 Mar. 16 at 2:54 PM
$LRMR Buying here
0 · Reply
Tony_37
Tony_37 Mar. 16 at 2:15 PM
$LRMR : why it red today 😅
1 · Reply
LFG2030
LFG2030 Mar. 16 at 12:39 PM
$ISPC $LRMR
0 · Reply
Nescu
Nescu Mar. 13 at 7:09 PM
$LRMR Who can explain me why would such a company experience a sell-off when all data and regulatory bodies show a good chance of approval of their drug? Fundamentally nothing have changed, but on the contrary, things have well improved on all sides
1 · Reply
Nescu
Nescu Mar. 13 at 5:59 PM
$LRMR What a crazy opportunity to buy stock in this company at this level thanks to the war in Iran. Considering the priority review vouchers upon approval, plus huge cash reverses, plus strong data so far, Breakthrough Therapy Designation, this is a no brainer. First in class treatment replacing the current standard of care and shifting the treatment paradigm of a drug bought initially for 7 billion dolars. When they report Top Line data in Q2 it will surge significantly. Whoever is not affraid to accumulate here, should be rewarded later on in less than 2 months
1 · Reply
jordan5
jordan5 Mar. 13 at 3:53 PM
$LRMR I’m loaded. No News
0 · Reply
BiotechStockFundManager
BiotechStockFundManager Mar. 13 at 2:53 PM
$LRMR I am buying some shares here.
1 · Reply